Your browser doesn't support javascript.
loading
Neumonitis intersticial secundaria a tratamiento con interferón pegilado / Pegylated interferon induced interstitial pneumonitis in a patient with hepatitis C infection
orres Macho, J; Jara Chinarro, B; Suárez Aliaga, B; Gámez Díez, S; García de Casasola, G; Cuenca Morón, B. de.
Affiliation
  • orres Macho, J; Hospital Infanta Cristina. Madrid. España
  • Jara Chinarro, B; Hospital Infanta Cristina. Madrid. España
  • Suárez Aliaga, B; Hospital Infanta Cristina. Madrid. España
  • Gámez Díez, S; Hospital Infanta Cristina. Madrid. España
  • García de Casasola, G; Hospital Infanta Cristina. Madrid. España
  • Cuenca Morón, B. de; Hospital Infanta Cristina. Madrid. España
Rev. esp. enferm. dig ; 102(10): 606-608, oct. 2010. ilus
Article in Spanish | IBECS | ID: ibc-82205
Responsible library: ES1.1
Localization: BNCS
RESUMEN
El interferón pegilado asociado a ribavirina es el tratamiento de elección en los pacientes con infección por hepatitis C crónica. Los efectos secundarios más comunes son los síntomas gripales y las alteraciones psiquiátricas. La neumonitis es una complicación poco frecuente, pero se asocia con una mortalidad no despreciable. Presentamos el caso clínico de un paciente con neumonitis intersticial asociada a interferón que presentaba signos y síntomas clínicos sutiles y una radiografía de tórax sin alteraciones. Se debe de tener presente esta entidad en el diagnóstico diferencial de los síntomas respiratorios en pacientes que reciben tratamiento con interferón debido a su elevada morbi-mortalidad y a su evolución favorable tras la retirada del fármaco(AU)
ABSTRACT
Pegylated interferon and ribavirin is the treatment of choice in patients with chronic hepatitis C infection. The most common side effects of interferon therapy are flu-like symptoms and psychiatric disorders. Pneumonitis is a less frequent complication associated with non-negligible mortality. We herein report a case of interferon associated pneumonitis in a patient with non-severe clinical symptoms and a normal chest radiography. Physicians should be aware of this entity during the differential diagnosis of respiratory symptoms in patients receiving treatment with interferon due to its high morbimortality and good resolution and outcome after drug withdrawal(AU)
Subject(s)
Full text: Available Collection: National databases / Spain Health context: SDG3 - Health and Well-Being / SDG3 - Target 3.3 End transmission of communicable diseases / SDG3 - Target 3.4 Reduce premature mortality due to noncommunicable diseases Health problem: Target 3.3: End transmission of communicable diseases / Hepatitis / Pneumonia / Digestive System Diseases / Other Respiratory Diseases Database: IBECS Main subject: Ribavirin / Interferons / Lung Diseases, Interstitial / Bronchoalveolar Lavage / Hepatitis C, Chronic Type of study: Diagnostic study Limits: Humans / Male Language: Spanish Journal: Rev. esp. enferm. dig Year: 2010 Document type: Article Institution/Affiliation country: Hospital Infanta Cristina/España
Full text: Available Collection: National databases / Spain Health context: SDG3 - Health and Well-Being / SDG3 - Target 3.3 End transmission of communicable diseases / SDG3 - Target 3.4 Reduce premature mortality due to noncommunicable diseases Health problem: Target 3.3: End transmission of communicable diseases / Hepatitis / Pneumonia / Digestive System Diseases / Other Respiratory Diseases Database: IBECS Main subject: Ribavirin / Interferons / Lung Diseases, Interstitial / Bronchoalveolar Lavage / Hepatitis C, Chronic Type of study: Diagnostic study Limits: Humans / Male Language: Spanish Journal: Rev. esp. enferm. dig Year: 2010 Document type: Article Institution/Affiliation country: Hospital Infanta Cristina/España
...